March 4, 2024

Understanding the complexity of catatonia

Written by Joao L. de Quevedo, MD, PhD Catatonia, a perplexing neuropsychiatric condition, often remains misunderstood despite its profound impact on individuals’ lives. Characterized by a range of motor disturbances, catatonia can manifest as immobility, repetitive movements, or even peculiar…

February 26, 2024

The Remarkable Journey of Electroconvulsive Therapy (ECT)

Written by Joao L. de Quevedo, MD, PhD In the annals of medical history, certain breakthroughs stand out as both controversial and groundbreaking. One such discovery that has sparked debates, evolved, and ultimately proven its efficacy is Electroconvulsive Therapy (ECT)….

February 19, 2024

Breaking Ground: MAPS PBC Submits First NDA to FDA for Psychedelic-Assisted Therapy

Written By: Dr. Joao De Quevedo In a historic leap forward for the field of mental health, the Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation (PBC) has achieved a groundbreaking milestone by submitting the first New Drug Application…

February 12, 2024

Calming and Grounding Techniques

Written By: Amy K. Garcia, PhD, NCSP, LP and Daniela Sosa-Castillo, LMSW Stress According to the World Health Organization (WHO), stress is defined as “a state of worry or mental tension caused by a difficult situation” (WHO, 2023). Humans all…

February 5, 2024

A Ray of Hope: FDA Approves Zuranolone for Postpartum Depression

Written By: Dr. Joao De. Quevedo In a groundbreaking moment for mental health, the Food and Drug Administration (FDA) has recently approved Zuranolone, a novel medication, to treat postpartum depression (PPD). This decision marks a significant step forward in addressing…

January 29, 2024

A New Dawn: FDA Greenlights Exxua (Gepirone ER) for Major Depressive Disorder

Written By: Dr. Joao De Quevedo In a significant stride towards advancing mental health treatment, the U.S. Food and Drug Administration (FDA) has recently approved Gepirone ER, a promising medication now available under the brand name Exxua. This breakthrough offers…

January 23, 2024

Bipolar Disorder

Written By: Dr. Joao De Quevedo What is bipolar disorder? Bipolar disorder, also known as manic-depressive illness, is a psychiatric condition that causes unusual shifts in mood state, sleep, energy and activity levels. The person can have a period of…

January 8, 2024


Written By: Dr. Joao De Quevedo What is seasonal affective disorder? Seasonal Affective Disorder (SAD) is a type of depression that follows a seasonal pattern. It is a mood-related condition that affects almost 5% of the U.S. population annually and…

January 2, 2024

The Genetics of Depression: Unraveling the Molecular Tapestry

Written by Dr. Joao De Quevedo Depression, a prevalent and debilitating mental health disorder, has long been recognized as having a multifactorial etiology, with genetic factors playing a substantial role. This essay delves into the intricate interplay between genetics and…

December 15, 2023

A Holiday Interview with Dr. Taiwo Babatope

An interview with Taiwo Babatope, MD: What are your thoughts on holiday traditions for children and families – like Christmas/Hannukah? Holiday traditions for children and families, such as Christmas and Hannukah celebrations, are deeply significant social rituals that go beyond…